Please wait while the formulary information is being retrieved.
NEBUPENT (PENTAMIDINE ISETHIONATE)
- Pneumocystis jiroveci pneumonia prevention
300 mg solution for inhalation
- Inhale 300 mg by nebulization route every 4 weeks
300 mg solution for inhalation
- Inhale 300 mg by nebulization route every 4 weeks
Pneumocystis jirovecii pneumonia
- Inhale 300 mg by nebulization route every 4 weeks
- None
Contraindicated
- clozapine
- Clozaril
- deferiprone
- Fazaclo
- Ferriprox
- Versacloz
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Bronchospastic pulmonary disease
NEBUPENT (PENTAMIDINE ISETHIONATE)
- Pneumocystis jiroveci pneumonia prevention
- Bronchospastic pulmonary disease
- Chest pain
- Cough
- Dyspnea
- Infection
- Pharyngitis
- Skin rash
- Wheezing
- Anorexia
- Fatigue
- Fever
More Frequent
Severe
Less Severe
- Anemia
- Colitis
- Esophagitis
- Influenza
- Bronchitis
- Diarrhea
- Dysgeusia
- Headache disorder
- Nausea
- Night sweats
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute pancreatitis
- Anaphylaxis
- Black tarry stools
- Extrapulmonary pneumocystosis
- Hypoglycemic disorder
- Kidney disease with reduction in GFR
- Pneumothorax
- SIADH syndrome
Less Severe
- Diabetes mellitus
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Pentamidine (inh)
No safety and efficacy established age < 16 years.
- 1 Day – 16 Years
- No safety and efficacy established age < 16 years.
Pentamidine Isethionate
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Pentamidine Isethionate
None
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Pneumocystis jiroveci pneumonia prevention | |
| B59 | Pneumocystosis |
| 0-9 | A-Z |
|---|---|
| B59 | Pneumocystosis |
Formulary Reference Tool